Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fremanezumab versus placebo for preventive treatment of episodic migraine in children and adolescents
MOH_2020-11-17_009499Phase 3Recruiting
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Nov 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Ajovy with Placebo (2 arms). Started Nov 2020; status: recruiting.
02
Drugs
fremanezumab
03
Conditions
migraine
Beyond the preview
Go deeper on MOH_2020-11-17_009499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-11-17_009499.